Myasthenia Gravis: Reflections on Past Challenges and Evolving Strategies
Nicholas J. Silvestri, MD, Associate Professor, Department of Neurology, University at Buffalo Jacobs School of Medicine & Biomedical Sciences; Staff Physician, UBMD, Buffalo, New York
Nicholas J. Silvestri, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Argenx; Alexion; Immunovant; UCB
Serve(d) as a speaker or a member of a speakers bureau for: Argenx; Alexion; UCB
Nicholas J. Silvestri, MD, recounts a memorable experience with a patient with myasthenia gravis (MG) during early neurology residency, detailing the diagnostic process and initial treatment with standard therapies. Despite the patient's positive response in terms of efficacy, tolerability issues and side effects posed challenges.
Dr Silvestri highlights the evolution in MG treatment, emphasizing the availability of newer, well-tolerated options with proven efficacy, suggesting a more balanced approach between effectiveness and patient safety in contemporary MG management.
,false